Loss of apolipoprotein E receptor LR11 in Alzheimer disease

Archives of Neurology

Volumn 61, Issue 8, 2004, Pages 1200-1205

  Scherzer, Clemens R ^a,e   Offe, Katrin ^a,b   Gearing, Marla ^a   Rees, Howard D ^a   Fang, Guofu ^a   Heilman, Craig J ^a   Schaller, Chica ^c   Bujo, Hideaki ^d   Levey, Allan I ^a,b,f   Lah, James J ^a,f  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d CHIBA UNIVERSITY   (Japan)

^e Brigham and Women's Hospital Center for Neurologic Diseases   (United States)

^f Center for Neurodegenerative Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E RECEPTOR LR11; GENE PRODUCT; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CELL LINE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPHOBLAST; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UNITED STATES; WESTERN BLOTTING;

EID: 4043141580     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.8.1200     Document Type: Article

References (33)

1. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease: hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann N Y Acad Sci. 2000;924:17-25.
2. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001; 81:741-766.
3. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet. 2000;356:1627-1631.
4. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglataryl coenzyme A reductase inhibitors. Arch Neurol. 2000;57:1439-1443.
5. Rockwood K, Kirkland S, Hogan DB, et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol. 2002;59:223-227.
6. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
7. Kang DE, Saitoh T, Chen X, et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology. 1997;49:56-61.
8. Okuizami K, Onodera O, Namba Y, et al. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease. Nat Genet 1995;11:207-209.
9. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:8098-8102.
10. Brendza RP, Bales KR, Paul SM, Holtzman DM. Role of apoE/Aβ interactions in Alzheimer's disease: insights from transgenic mouse models. Mol Psychiatry. 2002;7:132-135.
11. Puglielli L, Tanzi RE, Kovacs DM. Alzheimer's disease: the cholesterol connection, Nat Neurosci. 2003;6:345-351.
12. Di Luca M, Colciaghi F, Pastorino L, Borroni B, Padovani A, Cattabeni F. Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol. 2000; 405:277-283.
13. Ibarreta D, Parrilla R, Ayuso MS. Altered Ca2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 1997; 11:220-227.
14. Ibarreta D, Urcelay E, Parrilla R, Ayuso MS. Distinct pH homeostatic features in lymphoblasts from Alzheimer's disease patients. Ann Neurol. 1998;44:216-222.
15. Cecchi C, Latorraca S, Sorbi S, et al. Glutathione level is altered in lymphoblasts from patients with familial Alzheimer's disease. Neurosci Lett. 1999;275:152-154.
16. Li QX, Fuller SJ, Beyreuther K, Masters CL. The amyloid precursor protein of Alzheimer disease in human brain and blood. J Leukoc Biol. 1999;66:567-574.
17. Schlossmacher MG, Ostaszewski BL, Hecker LI, et al. Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes. Neurobiol Aging. 1992;13:421-434.
18. Citron M, Vigo-Pelfrey C, Teplow DB, et al. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A. 1994; 91:11993-11997.
19. Yamazaki H, Bujo H, Kusunoki J, et al. Elements of neural adhesion molecules and a yeast vacuolar protein sorting receptor are present in a novel mammalian low density lipoprotein receptor family member. J Biol Chem. 1996;271:24761-24768.
20. Jacobsen L, Madsen P, Moestrup SK, et al. Molecular characterization of a novel human hybrid-type receptor that binds the α2-macroglobulin receptor-associated protein. J Biol Chem. 1996;271:31379-31383.
21. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
22. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet. 1986;73:320-326.
23. Bandman O, Coleman RT, Loring JF, Seilhamer JJ, Cocks BG. Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. Ann N Y Acad Sci. 2002;975:77-90.
24. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001;158:1639-1651.
25. Hampe W, Riedel IB, Lintzel J, Bader CO, Franke I, Schaller HC. Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator. J Cell Sci. 2000;113:4475-4485.
26. Hirayama S, Bujo H, Yamazaki H, et al. Differential expression of LR11 during proliferation and differentiation of cultured neuroblastoma cells. Biochem Biophys Res Commun. 2000;275:365-373.
27. Govoni S, Gasparini L, Racchi M, Trabucchi M. Peripheral cells as an investigational tool for Alzheimer's disease. Life Sci. 1996;59:461-468.
28. Eckert A, Schindowski K, Leutner S, et al. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice. Neurobiol Dis. 2001;8:331-342.
29. Motoi Y, Aizawa T, Haga S, Nakamura S, Namba Y, Ikeda K. Neuronal localization of a novel mosaic apolipoprotein E receptor, LR11, in rat and human brain. Brain Res. 1999;833:209-215.
30. Herz J, Beffert U. Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat Rev Neurosci. 2000;1:51-58.
31. Jacobsen L, Madsen P, Nielsen MS, et al. The sorLA cytoplasmic domain interacts with GGA1 and -2 and defines minimum requirements for GGA binding. FEBS Lett. 2002;511:155-158.
32. Marcusson EG, Horazdovsky BF, Cereghino JL, Gharakhanian E, Emr SD. The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene. Cell. 1994;77:579-586.
33. Puertollano R, Aguilar RC, Gorshkova I, Crouch RJ, Bonifacino JS. Sorting of mannose 6-phosphate receptors mediated by the GGAs. Science. 2001;292: 1712-1716.